首页> 外国专利> aminoacylderivate 4.9 - dihydro - 10 - pyrido (3.2) thieno (3.2 - (e) (1.4) diazepinonen and 4.9 dihydro - 10 - pyrido (3.2) thieno (3,4 - (e) (1.4) diazepinonen,their manufacture and pharmaceutical preparations containing them.

aminoacylderivate 4.9 - dihydro - 10 - pyrido (3.2) thieno (3.2 - (e) (1.4) diazepinonen and 4.9 dihydro - 10 - pyrido (3.2) thieno (3,4 - (e) (1.4) diazepinonen,their manufacture and pharmaceutical preparations containing them.

机译:氨基酰基衍生物4.9-二氢-10-吡啶(3.2)噻诺(3.2-(e)(1.4)二氮杂萘酮和4.9二氢-10-吡啶(3.2)噻诺(3,4-(e)(1.4)二氮杂萘酮包含它们的制剂。

摘要

(A) N-Aminoacyl-pyrido (b)(1,4)-diazepine derivs. of formula (I) (including possible enantiomeric forms) and their salts with pharmaceutically innocuous acids are new: A = a gp. of formula (Ia) or (Ib); R1 = H or CH3; n = 0, 1 or 2; R2 = H or CH3, being H when n is 2; M = 5- or 6-membered cyclic amino residue (opt. contg. another hetero atom, e.g. O, S or N) when n is 1 or 2, or 1-methyl-piperidin-4-yl or 1-methyl-piperidin-3-yl when n is 0. (B) Also new and claimed are intermediates of formula (III) (see 'Preparation') when A is a residue of formula (Ia). (I) are prepd. by reaction of N-unsubstd. cpds. of formula (III) with acylchlorides of formula (IV) or with an activated deriv. of (iso)nipecotic acid and, when (IV) is used, reaction of the product with a cyclic amine selected from pyrolidine, thiazolidine, morpholine, piperidine, piperazine or 4-methy piperazine: where (X=Cl, Br or I).
机译:(A)N-氨基酰基-吡啶基(b)(1,4)-二氮杂pine衍生物。式(I)的化合物(包括可能的对映体形式)及其与药学上无害的酸的盐是新的:A = gp。具有式(Ia)或(Ib); R1 = H或CH3; n = 0、1或2; R2 = H或CH3,当n为2时为H;当n为1或2时,M = 5或6元环氨基残基(与另一个杂原子,例如O,S或N相连),或1-甲基哌啶-4-基或1-甲基哌啶当n为0时,为-3-基。(B)当A为式(Ia)的残基时,式(III)的中间体(参见“制备”)也是新的和要求保护的。 (一)准备。通过N-unsubstd的反应。 cpds。式(III)的化合物与式(IV)的酰氯或活化的衍生物。 (异)哌啶酸和(IV)使用时,产物与选自吡咯烷,噻唑烷,吗啉,哌啶,哌嗪或4-甲基哌嗪的环胺反应:(X = Cl,Br或I) 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号